Ambroxol is an expectorant drug that belongs to the group of expectorants. Ambroxol is indicated for secretolytic therapy in bronchopulmonary diseases with abnormal mucus secretion and transport. Mucus is more easily cleared and the patient's breathing is facilitated. It is often administered in the form of cough syrups, but is also given in lozenge form.
It was patented in 1966 and came into medical use in 1979.
- Acute/chronic bronchitis
- Cystic fibrosis